Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating restated by stock analysts at Canaccord Genuity in a report issued on Monday. They currently have a GBX 192 ($3.27) target price on the stock. Canaccord Genuity’s target price would indicate a potential upside of 48.55% from the stock’s previous close.

Shares of Vectura Group PLC (LON:VEC) opened at 132.734 on Monday. Vectura Group PLC has a 1-year low of GBX 76.00 and a 1-year high of GBX 171.50. The stock’s 50-day moving average is GBX 131.6 and its 200-day moving average is GBX 143.5. The company’s market cap is £530.5 million.

Several other analysts have also recently commented on the stock. Analysts at N+1 Singer cut their price target on shares of Vectura Group PLC from GBX 142 ($2.42) to GBX 135 ($2.30) in a research note on Wednesday, June 25th. They now have a “hold” rating on the stock. Separately, analysts at FinnCap reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Tuesday, June 24th. They now have a GBX 202 ($3.44) price target on the stock. Finally, analysts at Berenberg Bank raised their price target on shares of Vectura Group PLC from GBX 200 ($3.41) to GBX 210 ($3.58) in a research note on Friday, June 13th. They now have a “buy” rating on the stock. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of GBX 174.38 ($2.97).

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.